|
Clinical Intervention: Definitive (Phase III) Clinical or Translational Trials
Contributing journals to this collection:
Cancer Prevention Journals Portal,
Cancer Prevention Journals Portal Content,
Cancer Reviews Online,
Molecular Cancer Research,
Cancer Prevention Research,
Molecular Cancer Therapeutics,
Cancer Research,
Cancer Reviews Online Content,
Clinical Cancer Research,
and Cancer Epidemiology Biomarkers & Prevention
Citations 1-10 of 12 total displayed.
- Research Articles
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients
- Kathleen Settle, Marshall R. Posner, Lisa M. Schumaker, Ming Tan, Mohan Suntharalingam, Olga Goloubeva, Scott E. Strome, Robert I. Haddad, Shital S. Patel, Earl V. Cambell, III, Nicholas Sarlis, Jochen Lorch, and Kevin J. Cullen
Cancer Prevention Research 2009; 2: 776-781.
[Abstract]
[Full text]
[PDF]
[ Press Coverage ] [ Perspective on This Article ]
- Research Articles
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
- Monica M. Bertagnolli, Craig J. Eagle, Ann G. Zauber, Mark Redston, Aurora Breazna, KyungMann Kim, Jie Tang, Rebecca B. Rosenstein, Asad Umar, Donya Bagheri, Neal T. Collins, John Burn, Daniel C. Chung, Thomas Dewar, T. Raymond Foley, Neville Hoffman, Finlay Macrae, Ronald E. Pruitt, John R. Saltzman, Bruce Salzberg, Thomas Sylwestrowicz, Ernest T. Hawk, and for the Adenoma Prevention with Celecoxib Study Investigators
Cancer Prevention Research 2009; 2: 310-321.
[Abstract]
[Full text]
[PDF]
[ Perspective on this Article ] [ Supplementary Data ]
- Research Articles
The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers
- Wei Han, Joell J. Gills, Regan M. Memmott, Stephen Lam, and Phillip A. Dennis
Cancer Prevention Research 2009; 2: 370-376.
[Abstract]
[Full text]
[PDF]
- AACR Centennial Series
A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention
- V. Craig Jordan
Cancer Res. 2009; 69: 1243-1254.
[Abstract]
[Full text]
[PDF]
- Research Articles
Longitudinal Assessment of Air Conduction Audiograms in a Phase III Clinical Trial of Difluoromethylornithine and Sulindac for Prevention of Sporadic Colorectal Adenomas
- Christine E. McLaren, Sharon Fujikawa-Brooks, Wen-Pin Chen, Daniel L. Gillen, Daniel Pelot, Eugene W. Gerner, and Frank L. Meyskens, Jr.
Cancer Prevention Research 2008; 1: 514-521.
[Abstract]
[Full text]
[PDF]
[ Perspective on this Article ]
- Null Results in Brief
IGF-I, IGFBP-3, and IGF-I/IGFBP-3 Ratio: No Association with Incident Colorectal Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
- Joshua B. Max, Paul J. Limburg, Adeboye Ogunseitan, Rachael Z. Stolzenberg-Solomon, Robert A. Vierkant, Michael J. Pollak, Thomas A. Sellers, Jarmo Virtamo, James R. Cerhan, and Demetrius Albanes
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1832-1834.
[Full text]
[PDF]
- Research Article
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, and Eugene W. Gerner
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-08-0042.
[Abstract]
Online First [PDF]
[ Perspective on This Article ]
- Research Article
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
- Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, and Monica M. Bertagnolli
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-07-0011.
[Abstract]
Online First [PDF]
[ Perspective on This Article ]
- Cancer Therapy: Clinical
Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer
- Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway, Colin P. Dinney, David F. Penson, Surena Matin, Ashish Kamat, Louis L. Pisters, Daniel W. Lin, Ruth L. Katz, Dean E. Brenner, George P. Hemstreet, III, Mary Wargo, Archie Bleyer, William H. Sanders, John L. Clifford, Howard L. Parnes, and Scott M. Lippman
Clin. Cancer Res. 2008; 14: 224-229.
[Abstract]
[Full text]
[PDF]
- Research Articles
The Polyp Prevention Trial–Continued Follow-up Study: No Effect of a Low-Fat, High-Fiber, High-Fruit, and -Vegetable Diet on Adenoma Recurrence Eight Years after Randomization
- Elaine Lanza, Binbing Yu, Gwen Murphy, Paul S. Albert, Bette Caan, James R. Marshall, Peter Lance, Electra D. Paskett, Joel Weissfeld, Marty Slattery, Randall Burt, Frank Iber, Moshe Shike, James W. Kikendall, Brenda K. Brewer, Arthur Schatzkin the Polyp Prevention Trial Study Group
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1745-1752.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|